CELEX: 51989PC0388
Language: en
Date: 1989-07-27
Title: PROPOSAL FOR A COUNCIL DECISION CONCERNING THE CONCLUSION OF A COOPERATION AGREEMENT BETWEEN THE EUROPEAN ECONOMIC COMMUNITY AND THE KINGDOM OF NORWAY IN THE FIELD OF MEDICAL AND HEALTH RESEARCH

COMMISSION OF THE EUROPEAN COMMUNITIES
                                                              C0MC89) 388 final- SYN 215
                                                              Brussels, 27   July 1989
                                        Proposal for a
                                       COUNCIL DECISION
                concerning the conclusion of a Cooperation Agreement between
              the European Economic Community and the Kingdom of Norway in the
                            field of medical and health research
    ^•Sgl
                                (presented by the Commission)
•fiH
  J
   ^fetfcàî
 •Mi
 ---pagebreak---                                       - 2 -
                             EXPLANATORY MEMORANDUM
Subject:   Proposal for a Council Decision concerning the conclusion of a
           Cooperation Agreement between the European Economic Community and
           the Kingdom of Norway in the field of medical and health research.
    By its Decision of 17 November 1987 (1), the Council adopted a research
    and development programme of the Community in the field of medical and
    health research (1987 to 1991).      Article 7 of this Decision authorises
    the Commission to negotiate agreements with the non-member States
    participating in European cooperation in the field of scientific and
    technical research (COST) with a view to associate them wholly or partly
    with the programme.
2.  In the context o-f the implementation of the Framework Agreement for
    scientific and technical cooperation between the European Communities and
    the Kingdom of Norway, the conclusion of which on behalf of the EEC was
    approved by the Council Decision of 9 February 1987, Norway has expressed
    an interest in cooperating in some of the research targets of the
    above-mentioned orocramme.
3.  Comprehensive research and development activities in the field of
    medicine and health are carried out in Norway.         Bearing in mind the
    scientific and technical importance of these activities and considering
    that cooperation with Norway in the field of medical and health research
    is likely to contribute effectively to the attainment of an optimum level
    of individual and public health, the Commission has negotiated a draft
    cooperation agreement with Norway.
4.  The draft agreement, which is annexed to the attached proposal for a
    Council decision, provides for:
    -   cooperation for a period from 1 January 1989 to 31 December 1991 in
       the following reseach targets of the Community programme:
            .-  AIDS (Target 1.2),
             -   Age-related health problems (Target 1.3),
                Environment and life-style health problems (Target 1.4).
             -   Health services research (Target II.2)
       The cooperation consists of the coordination of the activities which
       form part of the research programmes of Norway and of the Community.
 ---pagebreak---                                    - 3-
   -  a financial contribution from Norway for the implementation of the
      coordination activities.   This financial contribution is proportional
      to Norway's gross domestic product and covers coordination costs,
      management and operating expenditure and fellowships.
   -  the enlargement of the f4anagement and Coordination Advisory Committee
      on medical and health research (CGC) and of the relevant Concerted
      Action Committees (COMACs) to include Norwegian representatives.
5. In view of the nature of the cooperation, any additional expenditure paid
   from the Community budget (relevant budget heading 7311) resulting from
   the implementation of this draft agreement will be covered by Norway's
   financial contribution.
   The funds paid by Norway will      be  credited to the   Community  budget
   (relevant budget article 602).
 ---pagebreak---                                       - 4 -
                                 Proposal for a
                                COUNCIL DECISION
concerning the conclusion of a Cooperation      Agreement between  the European
Economic Community   and the Kingdom of Norway     in the field of medical and
health research.
THE COUNCIL OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Economic Community, and
in particular Article 130 Q (2) thereof.
Having regard to the proposal from the Commission (1),
In cooperation with the European Parliament (2),
Having regard to the opinion of the Economic and Social Committee (3),
WHEREAS by   Decision 87/551/EEC   (4),     the Council adopted a research and
development coordination programme of the European Economic Community in the
field of medical and health research     (1987 to 1991);   whereas Article 7 of
this Decision   authorises the   Commission   to negotiate agreements with the
non-member States    participating  in- European cooperation   in the field of
scientific and technical research (COST) with a view to associate them wholly
or partly with this programme,
 (1) O.J.  N° C
 (2) O.J.  N° C
 (3) O.J.  N° C
 (4)  O.J. N° L 334, 24.11.1987, p. 20
 ---pagebreak---                                      - 5 -
WHEREAS by Decision 87/177/EEC (1),     the Council approved the conclusion on
behalf of the European Economic Community of the the Framework Agreement for
scientific and technical cooperation between the European Communities       and,
among others, the Kingdom of Norway,
WHEREAS the cooperation Agreement between the European Economic Community and
the Kingdom of Norway in the field of medical and health research should be
approved,
HAS DECIDED AS FOLLOWS:
Article 1
The Cooperation Agreement between the European      Economic Community   and the
Kingdom of Norway in the field of medical and health research,         is hereby
approved on behalf of the Community.
The text of the Agreement is attached to this Decision.
Article 2
The President of the Council shall carry out the notification as provided for
in Article 7 of the Agreement.
Article 3
The  present  Decision  shall  enter   into  force  on  the  day  following  its
publication in the Official Journal of the European Communities.
Done at ....
                                                             For the Council
                                                            The President
(1)  O.J. N° L  71, 14.03.1987, p. 29
 ---pagebreak---              - 6 -
     COOPERATION AGREEMENT
            BETWEEN
THE EUROPEAN ECONOMIC COMMUNITY
              AND
     THE KINGDOM OF NORWAY
        IN THE FIELD OF
  MEDICAL AND HEALTH RESEARCH
 ---pagebreak---                                     - 7 -
                            COOPERATION AGREEMENT
                                   BETWEEN
                       THE EUROPEAN ECONOMIC COMMUNITY
                                     AND
                            THE KINGDOM OF NORWAY
                               IN THE FIELD OF
                         MEDICAL AND HEALTH RESEARCH
THE EUROPEAN ECONOMIC COMMUNITY, hereinafter referred to as "the Community",
and
THE KINGDOM OF NORWAY, hereinafter referred to. as "Norway*,
both hereinafter referred to as "the Contracting Parties",
WHEREAS the Contracting Parties       concluded a Framework Agreement for
Scientific and Technical Cooperation which entered into force on 17 July
1987;
WHEREAS by its Decision of 17 November 1987, the Council of the European
Communities, hereinafter referred to as "the Council", adopted a research and
development coordination programme of the Community in the field of medical
and health research (1987 to 1991) which includes, among others, research
targets on AIDS, age-related health problems, environment and life-style
related health problems and health services research;
WHEREAS comprehensive research and development activities    in the field of
medical and health research are carried out in Norway;
WHEREAS cooperation in the field of medical and health research is likely to
contribute effectively to the attainment of an optimum level of individual
and public health;
WHEREAS the Member States of the Community and Norway intend, in accordance
with the rules and procedures applicable to their national programmes, to
carry out the research described in Annex A and are prepared to integrate
such research into a process of coordination which they consider will be of
mutual benefit;
HAVE AGREED AS FOLLOWS
 ---pagebreak---                                      -8 -
Article 1
The Contracting Parties shall cooperate for a period from 1 January 1989 to
31 December 1991 in the following research targets of the Community
programme:
-   AIDS (Target 1.2)
-   Age-related health problems (Target 1.3)
-   Environment and life-style related health problems (Target 1.4)
-   Health services research (Target II.2)
The research topics covered by this Agreement are outlined in Annex A.
The cooperation shall consist of the coordination of those activities which
form part of the research programmes of Norway and of the Community.
Norway and the Member States of the Community shall remain entirely
responsible for the research carried out by their national institutions or
bodies.
Article 2
The Commission of the European Communities, hereinafter referred to as "the
Commission", shall be responsible for the implementation of the coordination
activities.
It shall be assisted in its task by the Management and Coordination Advisory
Committee on Medical and Health Research, hereinafter referred to as the
"CGC", set up by Council Decision 84/338 (1).      This CGC may be assisted by
Concerted Action Committees (COMACs) composed of experts designated by the
competent authorities of Member States of the Community.
The CGC, together with those COMACs relevant to the research targets referred
to in Article 1, shall be enlarged to include two representatives designated
by Norway who may be assisted or replaced by one Norwegian expert.        These
representatives and/or experts shall attend meetings of the CGC and those
COMACs for all items relevant to those research targets.
Article 3
The    estimated   financial   contribution  from   the   Community   for   the
 implementation of the coordination activities covered by this Agreement shall
be set according to the amount available each year in the general budget of
the European Communities for appropriations covering commitments to meet
financial obligations of the Commission relating to coordination costs,
management and operating expenditure and fellowships.
7T)   OJ Nu L 177 of 04.07.1984, p. 25
 ---pagebreak---                                        - 9 -
The estimated financial contribution from Norway for the same costs and
expenditures shall be proportional to the Community's contribution.          The
proportionality factor shall be given by the ratio between Norway's gross
domestic product (GDP), at market prices, and the sum of gross domestic
products, at market prices, of the Member States of the Community and Norway.
This ratio shall be calculated on the basis of the latest available OECD
statistical data.
The total financial contributions from the Contracting Parties for the period
referred to in Article 1 are estimated to amount to:
-    24,190,000 Ecu from the Community
         470,979 Ecu from Norway
The Ecu is that defined by the Council Regulation (EEC) No 3180/78 of 18
December 1978 changing the value of the unit of account used by the European
Monetary Cooperation Fund (1), as amended by Regulation (EEC) No 2626/84 (2).
The rules governing the financial contribution from Norway are set out in
Annex B.
Article 4
During the course of its third year,         the Commission shall evaluate the
programme, having regard to the objectives of the research targets referred
to in Article 1.      As a result of this evaluation, the Commission may, after
the CGC has been consulted, submit to the Council a proposal for a revision
affecting some or all of these research targets. Norway shall be informed of
the results of this evaluation and of any possible revision.
Article 5
The Member States of the Community, Norway and the Commission shall regularly
exchange all useful information concerning the execution of the research
subjects covered by this Agreement.       The Member States of the Community and
Norway shall provide the Commission with all information necessary for
coordination purposes.      They shall also endeavour to provide the Commission
with information on similar research planned or carried out by bodies which
are not under their authority.           Any information shall be treated as
confidential if so requested by the party which provides it.
On completion of the coordination activities covered by this Agreement, the
Commission, in agreement with the CGC, shall send to the Member States of the
Community,      the European Parliament and Norway a summary report on the
implementation and results of the research.
Article 6
This Agreement shall apply, on the one hand, to the territories in which the
Treaty establishing the European Economic Community is applied and under the
conditions laid down in that Treaty and, on the other hand, to the territory
of the Kingdom of Norway.
T T ) O J Nu L 379 of 30.12.1978, p. 1
 (2) 0J N° L 247 of 16.09.1984, p. 1
 ---pagebreak---                                     - 10 -
Article 7
This Agreement shall be approved by the Contracting Parties in accordance
with their existing procedures.    It shall enter into force on the date on
which the Contracting Parties have notified each other of the completion of
the procedures necessary for this purpose.
Article 8
1.  This Agreement is concluded for the period referred to in Article 1.
    Should the Community revise the Community programme, the Agreement may be
    renegotiated or terminated under mutually agreed conditions.       Norway
    shall be notified of the exact content of the revised programme within
    one week after its adoption by the Community.     The Contracting Parties
    shall notify each other within three months after the Community decision
    has been adopted if a termination of the Agreement is envisaged.
2.  Whenever a decision on the Community programme is taken by the Community,
    Annexes A and B shall be amended in accordance with the Community's
    decision, unless otherwise agreed upon by the Contracting Parties.
3.  Excepted as provided in paragraph 1 of this Article, either Contracting
    Party may at any time terminate this Agreement with 6 months' notice.
Article 9
The Annexes A and B to this Agreement shall be an integral part thereof.
Article 10
This Agreement shall be drawn up in duplicate in the Danish, Dutch, English,
French, German, Greek, Italian, Portuguese, Spanish and Norwegian languages,
each of these texts being equally authentic.
Done at
                                                  For the Council
                                                  of the European Communities
                                                  For the Kingdom of Norway
 ---pagebreak---                                      - 11 -
                                    ANNEX A
                    RESEARCH TOPICS COVERED BY THE AGREEMENT
Target 1.2 - AIDS:
Area 1.2.1     Disease control and prevention
Area 1.2.2     Viro-immunological research
Area 1.2.3     Clinical research
Target 1.3 - AGE-RELATED HEALTH PROBLEMS:
Area 1.3.1     Reproduction
Area 1.3.2     Ageing and diseases
Area 1.3.3     Disabilities
Target 1.4 - ENVIRONMENT AND LIFE-STYLE HEALTH PROBLEMS:
Area 1.4.1     Breakdown in human adaption
Area 1.4.2     Nutrition
Area 1.4.3     Consumption of illicit drugs
Area 1.4.4     Infections
Target II.2 - HEALTH SERVICES RESEARCH: (1)
Area II.2.1    Research on prevention
Area II.2.2    Research on care delivery systems
Area II.2.3    Research on health care organisation
Area II.2.4    Health technology assessment
 (1)  The following actions will be carried out through seminars,  studies and
      exchange of personnel for training purposes:
      -  Evaluation of integrated non-communicable diseases prevention and
         control programmes (foreseen in Area II.2.1)
      -  Comprehensive community care of the mentally ill (foreseen in Area
         II.2.2)
      -  Health care planning and organisation (foreseen in Area II.2.3)
         Evaluation of clinical practive in hospitals (foreseen in Area
         II.2.3).
 ---pagebreak---                                      - T2 -
                                    ANNEX B
                                FINANCING RULES
Article 1
These provisions lay down the financing     rules for Norway   referred  to in
Article 3 of the Agreement.
Article 2
At the beginning of each year, or - in accordance with Article 8 of the
Agreement - whenever the Community programme is revised so as to involve an
increase in the amount estimated to be necessary for its implementation, the
Commission shall send to Norway a call for funds corresponding to its share
of the annual costs under the Agreement.
This contribution shall be expressed both in Ecu and in the Norwegian
currency.   The value .in Norwegian currency of the contribution in Ecu shall
be determined on the date of the call for funds.
The travel costs of Norwegian representatives and experts deriving from their
participation in the work of the CGC and COMACs referred to in Article 2 of
the Agreement, shall be reimbursed by the Commission in accordance with the
procedures currently in force for the representatives and experts of the
Member States of the Community on the due date.    The rate shall be increased
by 0.25 of a percentage point for each month of delay.
Norway shall pay its contribution to the annual costs under the Agreement at
the beginning of each year and at the latest three months after the call for
funds is sent. Any delay in the payment of the contribution shall give rise
to the payment of interest by Norway at a rate equal to the highest discount
rate in force in the Member States of the Community on the due date. The rate
shall be increased by 0.25 of a percentage point for each month of delay.
The increased rate shall be applied to the entire period of delay. However,
this interest shall be payable only if the contribution is paid more than
three months after a call for funds has been made by the Commission.
Article 3
The funds paid by Norway shall be credited to the four research targets as
budget receipts allocated to an appropriate heading in the statement of
revenue of the general budget of the European Communities.
Article 4
The provisional timetable for    the costs  referred to  in Article   3 of  the
Agreement are appended hereto.
 ---pagebreak---                                     - 13
Article 5
The Financial Regulations in force applicable to the general budget of the
European Communities shall apply to the management of the appropriations.
Art icle 6
At the end of each year, a statement of appropriations for the four research
targets shall be prepared and transmitted to Norway for information.
 ---pagebreak---                                            - 14 -
                              PROVISIONAL TIMETABLE FOR THE COSTS RELATING TO THE RESEARCH TARGETS (ECU)
                          Budget heading 7311 "Medical and Health research" (appropriations for commitments)
I                                     |     1987     |    1988     |     1989     |     1990      |    1991    |      TOTAL   |
|   I.     Initial estimate            I             I              I              I              I             I             I
|          of expenditure              |             j              j              j              |             |             I
I         - Target 1.2                |  2,160,000  |   3,500,000  |   4,000,000  |   3,340,000  |   1,000,000 |  14,000,000* |
I         - Target 1.3                j    580,000  j   1,670,000  |   2,200,000  |   2,400,000  |   2,150,000 |   9,000,000  |
I         - Target 1.4                |    250,000  |   1,350,000  |   1,650,000  |   1,400,000  |     850,000 |   5,500,000  |
I         - Target II.2               j    225,000  |   1,575,000  |   2,550,000  |   1,650,000  |   1,000,000 |   7,000,000  I
I                             Total   |  3,215,000  |   8,095,000  | 10,400,000   |   8,790,000  |   5,000,000 |  35,500,000  |
|   II.    Revised estimate of        j              |              |              |              |            |              I
|          expenditure taking into    I              I              I              I              I            I              I
|         account the Cooperation     |              |              |              |                        I       I         I
|         Agreement with Norway       |              |             |              |               I            I              I
|         -   Target 1.2              |  2,160,000 |    3,500,000 |    4,077,880 |    3,405,030 |    1,019,470 |  14,162,380*  |
I         -   Target 1.3              |    580,000 |    1,670,000 j    2,242,834 |    2,446,728 |    2,191,860 |   9,131,422  |
|         -   Target 1.4              |    250,000 j    1,350,000 |    1,682,126 |    1,427,257 |      866,550 |   5,575,933  |
I         -   Target II.2            j     225,000 |    1,575,000 |    2,599,649 |    1,682,125 |    1,019,470 |   7,101,244  |
I                             Total  |   3,215,000  |   8,095,000  | 10,602,489   |   8,961,140  |   5,097,350 |  35,970,979  |
|   III. Difference between II and |                I              I              I               !            I              I
j         and I to be covered by     |           0  |           0  j     202,489  |     171,140  |      97,350 i     470,979* j
|         Norway's contribution       |             |              |              I               I                I         I
  * Including support for "centralized facilities" for primates
 ---pagebreak---                FICHE 0'IMPACT SUR LA COMPETITIVITE ET L'EMPLOI
Ce projet a trait à une décision du Conseil concernant la conclusion d'un
accord de coopération entre la CEE et la Norvège dans le domaine de la
recherche médicale et sanitaire.
En tant que tel, ce projet peut avoir un impact positif sur les PME, dans la
mesure où il constitue un instrument facilitant l'accès à la connaissance et
à l'échange d'expériences.
                                                                          SS-
 ---pagebreak---  ---pagebreak---                                                                      ISSN 0254-1475
                                                              COM(89) 388 final
                                                      DOCUMENTS
EN                                                                          11 16
                                                                       27.7.1989
                                 Catalogue number : CB-CO-89-351-EN-C
                                                             ISBN 92-77-52430-8
Office for Official Publications of the European Communities
L-2985 Luxembourg